216 related articles for article (PubMed ID: 28554259)
21. Prognostic impact of persistent cytogenetic abnormalities at complete remission in adult patients with acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Jabbour EJ; O'Brien SM; Faderl S; Burger JA; Garris R; Qiao W; Huang X; Jain N; Konopleva M; Kadia TM; Daver N; Borthakur G; Cortes JE; Ravandi F
Am J Hematol; 2016 Jun; 91(4):385-9. PubMed ID: 26800008
[TBL] [Abstract][Full Text] [Related]
22. IK6 isoform with associated cytogenetic and molecular abnormalities in Chinese patients with Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Yao L; Cen J; Chen S; Shen H; Chen Y; He J; Chen Z
Leuk Lymphoma; 2013 Aug; 54(8):1626-32. PubMed ID: 23150929
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic significance of chromosome analysis in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
Hyakuna N; Kaneko Y; Katano N; Iwai T; Nagata T; Sakashita K; Takeda O; Tanaka A; Azuma H; Sekine I; Fujimoto T
Rinsho Ketsueki; 2000 Jul; 41(7):576-84. PubMed ID: 11020981
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Short NJ; Kantarjian HM; Sasaki K; Cortes JE; Ravandi F; Thomas DA; Garcia-Manero G; Khouri I; Kebriaei P; Champlin RE; Pierce S; Issa GC; Konopleva M; Kadia TM; Bueso-Ramos C; Khoury JD; Jain N; O'Brien SM; Jabbour E
Cancer; 2016 Dec; 122(24):3812-3820. PubMed ID: 27508525
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between karyotypic characteristics and treatment outcome in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Chen J; Dong L; Chen J; Pan C; Ye H; Xue HL; Tang JY; Wang YP
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):339-43. PubMed ID: 16875587
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.
Jain P; Gu J; Kanagal-Shamanna R; Tang Z; Patel KP; Yao H; Fang L; Bao HY; Liu CH; Lin P; Medeiros LJ; Lu X
Leuk Res; 2019 Sep; 84():106176. PubMed ID: 31279181
[TBL] [Abstract][Full Text] [Related]
27. Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Fedullo AL; Messina M; Elia L; Piciocchi A; Gianfelici V; Lauretti A; Soddu S; Puzzolo MC; Minotti C; Ferrara F; Martino B; Chiusolo P; Calafiore V; Paolini S; Vignetti M; Vitale A; Guarini A; Foà R; Chiaretti S
Haematologica; 2019 Feb; 104(2):312-318. PubMed ID: 30190342
[TBL] [Abstract][Full Text] [Related]
28. [Cytogenetic and prognostic analysis in adult patients with Philadelphia chromosome-positive and bcr-abl positive acute lymphoblastic leukaemia].
Li YN; Zou DH; Gu M; Zhao YZ; Qi JY; Mi YC; Wang JX; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):298-302. PubMed ID: 19799123
[TBL] [Abstract][Full Text] [Related]
29. [Chromosomal abnormalities and their clinical significance in acute lymphoblastic leukemia in adults].
Xue Y; Li J; Xia X
Zhonghua Nei Ke Za Zhi; 1997 Mar; 36(3):190-2. PubMed ID: 10374315
[TBL] [Abstract][Full Text] [Related]
30. Concomitance of monosomal karyotype with at least 5 chromosomal abnormalities is associated with dismal treatment outcome of AML patients with complex karyotype - retrospective analysis of Polish Adult Leukemia Group (PALG).
Wierzbowska A; Wawrzyniak E; Siemieniuk-Rys M; Kotkowska A; Pluta A; Golos A; Robak T; Szarawarska M; Jaskowiec A; Duszenko E; Rybka J; Holojda J; Grosicki S; Pienkowska-Grela B; Woroniecka R; Ejduk A; Watek M; Wach M; Mucha B; Skonieczka K; Czyzewska M; Jachalska A; Klonowska A; Iliszko M; Knopinska-Posluszny W; Jarmuz-Szymczak M; Przybylowicz-Chalecka A; Gil L; Kopacz A; Holowiecki J; Haus O
Leuk Lymphoma; 2017 Apr; 58(4):889-897. PubMed ID: 27561449
[TBL] [Abstract][Full Text] [Related]
31. [Cytogenetic and clinical study of Philadelphia chromosome positive adult acute leukemia].
Qiu JY; Zhu W; Zhang Y; Chen SS; Jiang B; Shi HL; Shi Y; He Q; Dang H; Wang DB; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):358-63. PubMed ID: 15972120
[TBL] [Abstract][Full Text] [Related]
32. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
[TBL] [Abstract][Full Text] [Related]
33. Frequency of chromosomal abnormalities in Pakistani adults with acute lymphoblastic leukemia.
Shaikh MS; Adil SN; Shaikh MU; Khurshid M
Asian Pac J Cancer Prev; 2014; 15(21):9495-8. PubMed ID: 25422245
[TBL] [Abstract][Full Text] [Related]
34. Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
Uckun FM; Nachman JB; Sather HN; Sensel MG; Kraft P; Steinherz PG; Lange B; Hutchinson R; Reaman GH; Gaynon PS; Heerema NA
Leuk Lymphoma; 1999 Mar; 33(1-2):101-6. PubMed ID: 10194126
[TBL] [Abstract][Full Text] [Related]
35. Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia.
Lafage-Pochitaloff M; Baranger L; Hunault M; Cuccuini W; Lefebvre C; Bidet A; Tigaud I; Eclache V; Delabesse E; Bilhou-Nabéra C; Terré C; Chapiro E; Gachard N; Mozziconacci MJ; Ameye G; Porter S; Grardel N; Béné MC; Chalandon Y; Graux C; Huguet F; Lhéritier V; Ifrah N; Dombret H;
Blood; 2017 Oct; 130(16):1832-1844. PubMed ID: 28790105
[TBL] [Abstract][Full Text] [Related]
36. Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Li Y; Qiu L; Zou D; Zhao Y; Mi Y; Wang J
Ann Hematol; 2009 Nov; 88(11):1069-77. PubMed ID: 19277658
[TBL] [Abstract][Full Text] [Related]
37. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
Moorman AV; Harrison CJ; Buck GA; Richards SM; Secker-Walker LM; Martineau M; Vance GH; Cherry AM; Higgins RR; Fielding AK; Foroni L; Paietta E; Tallman MS; Litzow MR; Wiernik PH; Rowe JM; Goldstone AH; Dewald GW;
Blood; 2007 Apr; 109(8):3189-97. PubMed ID: 17170120
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Effect of Complex Karyotype, Monosomal Karyotype, and Chromosome 17 Abnormalities in B-Cell Acute Lymphoblastic Leukemia.
Khoral P; Atenafu EG; Craddock KJ; Schimmer A; Chang H
Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):215-219. PubMed ID: 28395813
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic significance of Ph-positive acute lymphoblastic leukemia].
Zhou L; Hu J; Chen J; Du S; Wang A; You J; Wu W; Shen Z; Li J
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):109-13. PubMed ID: 24606650
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.
Gómez-Seguí I; Cervera J; Such E; Martínez-Cuadrón D; Luna I; Ibáñez M; López-Pavía M; Gascón A; Roig M; Martínez J; Sanz J; Montesinos P; Martín-Aragonés G; Lorenzo I; Senent L; Barragán E; Cordón L; Sempere A; Sanz GF; Sanz MA
Ann Hematol; 2012 Jan; 91(1):19-25. PubMed ID: 21935650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
